Chamber depth, iris curvature may significantly affect risk of acute primary angle closure

Article

Shallower anterior chamber depth (ACD) and a smaller iris curvature (I-Curv) are the two primary anterior segment biometric parameters associated with acute primary angle closure during an attack, according to a recent study published in Ophthalmology.

Shallower anterior chamber depth (ACD) and a smaller iris curvature (I-Curv) are the two primary anterior segment biometric parameters associated with acute primary angle closure during an attack, according to a recent study published in Ophthalmology.

For this prospective, comparative case series, 31 consecutive patients with acute primary angle closure were included. Mean patient age was 60 years, mean IOP was 3.8 mmHg in the eye with acute primary angle closure and 4.2 mmHg in the fellow eye before treatment (P

All patients underwent AS-OCT imaging of both eyes before therapeutic interventions were undertaken. Custom software was used to measure ACD, anterior chamber area (ACA), anterior chamber volume (ACV), I-Curv, iris area (I-Area), lens vault (LV), angle opening distance (AOD750), trabecular iris space area (TISA750), and iris thickness at 750 μm from the scleral spur (IT750).

After adjusting for pupil diameter, researchers found that APAC eyes had smaller ACD, ACA, ACV, I-Curv (all P

An optimal model that was comprised of pupil diameter, ACD, and I-Curv explained 36.7% of the variance in the occurrence of acute primary angle closure, with ACD accounting for 18.1%, and I-Curv for 14.1% of this variance.

"These findings present new insights into the anterior segment biometric parameters of acute primary angle closure and fellow eyes before therapeutic interventions," noted C.A. Chelvin, MBBChir, FRCS(Ed) and fellow researchers from the Singapore Eye Research Institute and Singapore National Eye Center, Singapore. "Anatomic changes in the anterior segment explained only about one-third of the variance in acute primary angle closure occurrence, and the role of nonanatomic factors require further investigation," they concluded.

For study results, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
© 2025 MJH Life Sciences

All rights reserved.